Trial Profile
A Real-Life Observational Study Assessing Effect Of Smoking And Organ Damage Alongwith Other Predictors On Belimumab Treatment Response In Patients From Three Swedish Clinical Practice Settings.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics; Therapeutic Use
- 01 Feb 2017 New trial record